421 results on '"Goldstein, E. J."'
Search Results
2. Comparative Activity of Moxifloxacin in Vitro Against Obligately Anaerobic Bacteria
3. Two decades of imipenem therapy
4. Pharmacodynamics and potential clinical role of garenoxacin against anaerobic pathogens
5. Sequence conservation and distribution of the fusobacterial immunosuppressive protein gene, fipA
6. COMPARATIVE IN VITRO ACTIVITY OF GEMIFLOXACIN AGAINST AEROBIC AND ANAEROBIC PATHOGENS ISOLATED FROM ANTRAL SINUS PUNCTURES FROM PATIENTS WITH SINUSITIS
7. SERUM BACTERICIDAL ACTIVITY OF GATIFLOXACIN AGAINST AEROBIC & ANAEROBIC RESPIRATORY PATHOGENS
8. U.S.-Based National Surveillance for Fidaxomicin Susceptibility of Clostridioides difficile-Associated Diarrheal Isolates from 2013 to 2016
9. U.S.-Based National Sentinel Surveillance Study for the Epidemiology of Clostridium difficile-Associated Diarrheal Isolates and Their Susceptibility to Fidaxomicin
10. Pathway to Prevention of Nosocomial Clostridium difficile Infection
11. Detection of antibiotic resistance factors in Gram negative anaerobic clinical isolates
12. Relapse Versus Reinfection: Recurrent Clostridium difficile Infection Following Treatment With Fidaxomicin or Vancomycin
13. Clinical Efficacy and Correlation of Clinical Outcomes With In Vitro Susceptibility for Anaerobic Bacteria in Patients With Complicated Intra-abdominal Infections Treated With Moxifloxacin
14. Eikenella corrodens as a cause of osteomyelitis in the feet of diabetic patients. Report of three cases.
15. In Vitro Activity of Ceftaroline against 623 Diverse Strains of Anaerobic Bacteria
16. Comparative in vitro activity of REP3123 against Clostridium difficile and other anaerobic intestinal bacteria
17. Clinical Outcomes, Safety, and Pharmacokinetics of OPT-80 in a Phase 2 Trial with Patients with Clostridium difficile Infection
18. Role of Folate Antagonists in the Treatment of Methicillin-Resistant Staphylococcus aureus Infection
19. National Survey on the Susceptibility of Bacteroides fragilis Group: Report and Analysis of Trends in the United States from 1997 to 2004
20. Necrotizing Soft-Tissue Infection: Diagnosis and Management
21. Acute Respiratory Infection Due to Chlamydia pneumoniae: Current Status of Diagnostic Methods
22. Antimicrobial-Associated QT Interval Prolongation: Pointes of Interest
23. Fluoroquinolones and Anaerobes
24. Intra-abdominal infections: review of the bacteriology, antimicrobial susceptibility and the role of ertapenem in their therapy
25. Introduction
26. In Vitro Activities of Ramoplanin, Teicoplanin, Vancomycin, Linezolid, Bacitracin, and Four Other Antimicrobials against Intestinal Anaerobic Bacteria
27. Sequence conservation and distribution of the fusobacterial immunosuppressive protein gene, fip A
28. Multilaboratory Comparison of Growth Characteristics for Anaerobes, Using 5 Different Agar Media
29. National Survey on the Susceptibility ofBacteroides fragilisGroup: Report and Analysis of Trends for 1997–2000
30. Comparative in vitro activity of faropenem and 11 other antimicrobial agents against 405 aerobic and anaerobic pathogens isolated from skin and soft tissue infections from animal and human bites
31. Multilaboratory Comparison of Anaerobe Susceptibility Results Using 3 Different Agar Media
32. Evolution and Current Use of the Tuberculin Test
33. Comparative in vitro activity of ertapenem and 11 other antimicrobial agents against aerobic and anaerobic pathogens isolated from skin and soft tissue animal and human bite wound infections
34. State-of-the-Art Treatment of Chronic Venous Disease
35. Review of the in vitro activity of gemifloxacin against Gram-positive and Gram-negative anaerobic pathogens
36. Characterization of Bacteroides forsythus Strains from Cat and Dog Bite Wounds in Humans and Comparison with Monkey and Human Oral Strains
37. Impact of adding prophylactic probiotics to a bundle of standard preventative measures for Clostridium difficile infections: enhanced and sustained decrease in the incidence and severity of infection at a community hospital.
38. Characterization of Bacteroides forsythus Strains from Cat and Dog Bite Wounds in Humans and Comparison with Monkey and Human Oral Strains
39. Trovafloxacin compared with levofloxacin, ofloxacin, ciprofloxacin, azithromycin and clarithromycin against unusual aerobic and anaerobic human and animal bite-wound pathogens
40. New horizons in the bacteriology, antimicrobial susceptibility and therapy of animal bite wounds
41. Growth characteristics and a novel method for identification (the WEE-TAB system) of Porphyromonas species isolated from infected dog and cat bite wounds in humans
42. Immunoblot Characterization ofPorphyromonasSpecies from Infected Dog and Cat Bite Wounds in Humans
43. Use of Polymerase Chain Reaction Fingerprinting to Compare Clinical Isolates of Bacteroides fragilis and Bacteroides thetaiotaomicron from Germany and the United States
44. Bilophila wadsworthiaClinical Isolates Compared by Polymerase Chain Reaction Fingerprinting
45. In vitro activity of Bay 12-8039, a new 8-methoxyquinolone, compared to the activities of 11 other oral antimicrobial agents against 390 aerobic and anaerobic bacteria isolated from human and animal bite wound skin and soft tissue infections in humans
46. Comparative in vitro activities of DU-6859a, levofloxacin, ofloxacin, sparfloxacin, and ciprofloxacin against 387 aerobic and anaerobic bite wound isolates
47. The Standard of Care Is Not So Standard
48. Characterization of saccharolytic Bacteroides and Prevotella isolates from infected dog and cat bite wounds in humans
49. Characterization of Indole-Negative Bacteroides fragilis Group Species with Use of Polymerase Chain Reaction Fingerprinting and Resistance Profiles
50. Frequency of Isolation of Porphyromonas Species from Infected Dog and Cat Bite Wounds in Humans and Their Characterization by Biochemical Tests and Arbitrarily Primed-Polymerase Chain Reaction Fingerprinting
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.